Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings

[ad_1]

A photo showing the logo of Swiss pharmaceutical giant Roche in Basel.

SEBASTIEN BOZON | AFP | Getty Images

Swiss health care company Roche announced it would acquire Telavant Holdings Monday, in a deal worth $7.1 billion.

Telavant creates drugs for people suffering from inflammatory and fibrotic diseases, and is in the process of developing a "promising new therapy" for patients with Crohn's disease, Roche said in a press release.

This is a breaking news story, please check back later for more.

[ad_2] Source link https://worldnews2023.com/top-stories/swiss-pharma-giant-roche-agrees-7-1-billion-deal-to-buy-telavant-holdings/?feed_id=305695&_unique_id=66650006a8e9d

Comments

Popular posts from this blog

Real Housewives of Beverly Hills couple Kyle Richards and Mauricio Umansky ‘seperate’

Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say

Casemiro has improved Man Utd: Maguire | The Express Tribune